Pages that link to "Q33708624"

The following pages link to DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status (Q33708624):

Displaying 44 items.

• MiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer (Q26775086) (← links)
• Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer (Q28087759) (← links)
• Integrated analysis of DNA methylation, immunohistochemistry and mRNA expression, data identifies a methylation expression index (MEI) robustly associated with survival of ER-positive breast cancer patients (Q30910707) (← links)
• DNA Methylation in Breast Tumor from High-risk Women in the Breast Cancer Family Registry (Q33893710) (← links)
• Investigation of DNA damage response and apoptotic gene methylation pattern in sporadic breast tumors using high throughput quantitative DNA methylation analysis technology. (Q34419090) (← links)
• Methylated genes in breast cancer: associations with clinical and histopathological features in a familial breast cancer cohort (Q35050475) (← links)
• Methylome analysis and epigenetic changes associated with menarcheal age (Q35053159) (← links)
• Association of childhood chronic physical aggression with a DNA methylation signature in adult human T cells (Q35137656) (← links)
• Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia (Q35155449) (← links)
• FOXA1 repression is associated with loss of BRCA1 and increased promoter methylation and chromatin silencing in breast cancer. (Q35602325) (← links)
• DiseaseMeth: a human disease methylation database (Q35631191) (← links)
• DNA methylation profiling reveals a predominant immune component in breast cancers. (Q36038847) (← links)
• DNA methylation signatures for breast cancer classification and prognosis (Q36245189) (← links)
• The signature of maternal rearing in the methylome in rhesus macaque prefrontal cortex and T cells (Q36375535) (← links)
• DNA methylation profiling to assess pathogenicity of BRCA1 unclassified variants in breast cancer (Q36833424) (← links)
• BRCA1 positively regulates FOXO3 expression by restricting FOXO3 gene methylation and epigenetic silencing through targeting EZH2 in breast cancer (Q36846719) (← links)
• Luminal B breast cancer subtype displays a dicotomic epigenetic pattern (Q36910353) (← links)
• Tumour morphology of early-onset breast cancers predicts breast cancer risk for first-degree relatives: the Australian Breast Cancer Family Registry (Q36924465) (← links)
• Oestrogen receptor negativity in breast cancer: a cause or consequence? (Q37529397) (← links)
• Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum (Q37639092) (← links)
• Mediators and dynamics of DNA methylation (Q37794100) (← links)
• Cancer Epigenome (Q37797702) (← links)
• Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers (Q37933098) (← links)
• Epigenetics of estrogen receptor-negative primary breast cancer (Q38012175) (← links)
• Epigenetic mechanisms of breast cancer: an update of the current knowledge (Q38296760) (← links)
• Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer (Q38503758) (← links)
• Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma (Q39246205) (← links)
• MTA1 expression correlates significantly with ER-alpha methylation in breast cancer (Q39340427) (← links)
• Panel sequencing of 264 candidate susceptibility genes and segregation analysis in a cohort of non-BRCA1, non-BRCA2 breast cancer families. (Q40070779) (← links)
• DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables (Q41132483) (← links)
• BRCA2 carriers with male breast cancer show elevated tumour methylation (Q41274606) (← links)
• Eagles report: Developing cancer biomarkers from genome-wide DNA methylation analyses (Q41837243) (← links)
• Methylation profiling of 48 candidate genes in tumor and matched normal tissues from breast cancer patients (Q42472194) (← links)
• Downregulation of E-cadherin expression in breast cancer by promoter hypermethylation and its relation with progression and prognosis of tumor (Q50628652) (← links)
• Heritable DNA methylation marks associated with susceptibility to breast cancer. (Q52371352) (← links)
• Epigenetic variations in breast cancer progression to lymph node metastasis. (Q53633720) (← links)
• Promoter methylation status and expression of estrogen receptor alpha in familial breast cancer patients. (Q54348663) (← links)
• Etiology of familial breast cancer with undetected BRCA1 and BRCA2 mutations: clinical implications. (Q54488788) (← links)
• Gene-specific methylation profiles in BRCA-mutation positive and BRCA-mutation negative male breast cancers. (Q55030444) (← links)
• The genesis and evolution of high-grade serous ovarian cancer (Q55053523) (← links)
• Epigenome-wide association study in the European Prospective Investigation into Cancer and Nutrition (EPIC-Turin) identifies novel genetic loci associated with smoking (Q57054077) (← links)
• The Cytoscan HD Array in the Diagnosis of Neurodevelopmental Disorders (Q57652244) (← links)
• Search for new genes involved in breast tumorigenesis by "Omics" analysis (Q82313928) (← links)
• Genetic and epigenetic profiling of BRCA1/2 in ovarian tumors reveals additive diagnostic yield and evidence of a genomic BRCA1/2 DNA methylation signature (Q96127103) (← links)